Search Results - "Den, R.B."

First Prospective Results Assessing the Clinical Utility and Clinical Benefit of Genomic Classifier Testing in Men Post-Prostatectomy.

Authors: Den, R.B. Marascio, J.A. Spratt, D.E. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE274-E274. 1p.

Subjects: Travel costs, Research grants

The Frequency of Druggable Targets in Localized Prostate Cancer: Initial Analysis From a Commercially Available Genomic Expression Database in Urologic Cancer.

Authors: Den, R.B. Davicioni, E. Takhar, M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pE251-E252. 1p.

Subjects: Prostate cancer treatment, Targeted drug delivery, Prostate cancer & genetics, Prostate cancer patients, Gene expression, Medical databases

Efficacy of Postoperative Radiation in a Prostatectomy Cohort Adjusted for Clinical and Genomic Risk.

Authors: Den, R.B. Yousefi, K. Trock, B. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pS103-S104. 1p.

Subjects: Prostate cancer treatment, Prostatectomy, Cancer radiotherapy, Prostate cancer & genetics, Oncologic surgery, Medical research

Validation of a Genomic Classifier for Prediction of Metastasis Following Postoperative Salvage Radiation Therapy.

Authors: Den, R.B. Choeurng, V. Howard, L. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2015 Supplement, Vol. 93 Issue 3, pS134-S134. 1p.

Subjects: Cancer radiotherapy, Metastasis, Cancer treatment, Genomics, Postoperative care, Salvage therapy, Cancer patients

Validation of a Genomic Classifier for Predicting Metastasis Following Postoperative Radiation Therapy in High-Risk Prostate Cancer.

Authors: Den, R.B. Karnes, R. Feng, F.Y. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS157-S157. 1p.

Subjects: Genomics, Cancer radiotherapy, Metastasis, Postoperative care, Prostate cancer risk factors

Predictors of Radiation Oncology Resident Research Productivity

Authors: Gutovich, J. Den, R.B. Werner-Wasik, M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2012 Supplement, Vol. 84, pS531-S531. 1p.

In Vivo Dosimeters Identify Delivered Doses That Exceed Planned Doses for Prostate Cancer Radiotherapy

Authors: Nowak, K. Den, R.B. Cao, J. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2011 Supplement, Vol. 81 Issue 2, pS212-S212. 1p.

Should Hypopharynx Cancer Continue to be Included in ‘Multi-head and Neck’ Trials within the RTOG?

Authors: Den, R.B. Zhang, Q. Cognetti, D. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2010 Supplement 1, Vol. 78 Issue 3, pS174-S174. 1p.

Toxicity of Phase I Radiation Oncology Trials: Worldwide Experience

Authors: Glass, C. Den, R.B. Dicker, A.P. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2010 Supplement 1, Vol. 78 Issue 3, pS65-S65. 1p.

Fractionated Stereotactic Radiotherapy for the Management of Optic Nerve Sheath Meningiomas

Authors: Den, R.B. Tjoumakaris, S. Werner-Wasik, M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2009 Supplement, Vol. 75 Issue 3, pS486-S486. 1p.

Photon Based Fractionated Radiotherapy and Radiosurgery for the Treatment of Chordomas and Chondrosarcomas: A Multi-Institutional Review

Authors: Den, R.B. Goldberg, Y. Werner-Wasik, M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2008 Supplement, Vol. 72 Issue s1, pS204-S204. 1p.

Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer.

Authors: Phillips, R. Proudfoot, J. Davicioni, E. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2023 Supplement, Vol. 117 Issue 2, pS34-S35. 2p.

Long-Term Follow-Up Evaluation of Efficacy in Alpha-Emitting Radiation Therapy on Recurrent and Locally Advanced Squamous Cell Carcinomas in Multi-Center Clinical Study.

Authors: Kurman, N. Mizrachi, A. Rosenfeld, E. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2022 Supplement, Vol. 114 Issue 3, pe546-e546. 1p.

Transcriptomic Heterogeneity in Pathological Grade Group 5 Prostate Cancer: Implications for Biomarker Discovery.

Authors: Kishan, A.U. Romero, T. Grogan, T. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE286-E287. 2p.

Long-Term Update of NRG Oncology RTOG 94-08.

Authors: Jones, C.U. Pugh, S. Sandler, H.M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pS31-S32. 2p.

Interprofessional Image Verification Workshop for Physician and Physics Residents: A Multi-Institutional Experience.

Authors: Padilla, L. Burmeister, J.W. Burnett III, O.L.L. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe433-e433. 1p.

A Pilot Trial Using Telehealth in Radiation Oncology: The Future of Healthcare is Virtual.

Authors: Miller, R.C. Simone, B. Nowak Choi, K.A. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pS53-S53. 1p.

Long-Term Competing Risk of Death In Prostate Cancer Patients After Prostatectomy.

Authors: Zaorsky, N.G. Stoltzfus, K. Lin, C. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe903-e903. 1p.

Clinical-Genomic Sub-classification of High-Risk Prostate Cancer: Implications for Tailoring Therapy and Clinical Trial Design.

Authors: Muralidhar, V. Alshalalfa, M. Spratt, D.E. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe854-e854. 1p.

Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial.

Authors: Spratt, D.E. Dess, R.T. Efstathiou, J.A. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2019, Vol. 105 Issue 3, p680-680. 1p.